153 results
Page 2 of 8
6-K
EX-99.2
w7je tp52
12 Jul 22
Bellus Health Announces Positive End-of-Phase 2 Meeting with the FDA and its CALM Phase 3 Program for BLU-5937 in Refractory Chronic Cough
7:27am
6-K
EX-99.1
lw8 tfpx7w3rqwny
12 Jul 22
Bellus Health Announces Positive End-of-Phase 2 Meeting with the FDA and its CALM Phase 3 Program for BLU-5937 in Refractory Chronic Cough
7:27am
6-K
EX-99.1
zsc n0o16bqv
5 Jul 22
BELLUS Health to Participate in the William Blair Biotech Focus Conference
7:00am
6-K
EX-99.1
vrx8 i8auitt46cb9qus
1 Jun 22
BELLUS Health to Participate in the Jefferies Healthcare Conference
7:00am
6-K
EX-99.1
vz7bmhnicwon124fm585
11 May 22
BELLUS Health Reports First Quarter 2022 Financial Results and Business Highlights
5:23pm
6-K
EX-99.2
664ou
11 May 22
Condensed Consolidated Interim Financial Statements of
5:05pm
6-K
EX-99.2
jenp tkvz29l
7 Apr 22
Notice of Annual Meeting of Shareholders
9:01am
6-K
EX-99.1
o8rb8poa mhkgw2qamd
5 Apr 22
Current report (foreign)
4:07pm
40-F
EX-99.1
etjibix6dnwv25ep66
23 Feb 22
Annual report (Canada)
5:20pm
40-F
EX-99.3
vhcd0o2
23 Feb 22
Annual report (Canada)
5:20pm
6-K
EX-99.1
vrmw4nk7gyfq2q2lbn7
23 Feb 22
BELLUS Health Reports Year 2021 Financial Results and Business Highlights
4:01pm
SUPPL
twijt
15 Dec 21
Supplemental materials (foreign)
5:10pm
F-10
5jloa 69x8yf8vx3fj0l
14 Dec 21
Registration of securities (Canada)
9:43am
SUPPL
a08bu75 a4db1qzpdsx
13 Dec 21
Supplemental materials (foreign)
5:00pm
6-K
EX-99.2
um09nk9od0gglmxlp1
13 Dec 21
BELLUS Health Announces Positive Topline Results from its Phase 2b SOOTHE Trial of BLU-5937 for the Treatment of Refractory Chronic Cough
7:19am
6-K
EX-99.1
9nuvs2n 4lgx
13 Dec 21
BELLUS Health Announces Positive Topline Results from its Phase 2b SOOTHE Trial of BLU-5937 for the Treatment of Refractory Chronic Cough
7:19am
6-K
EX-99.1
avt27d 24d6tuxjfpuf
13 Dec 21
BELLUS Health Announces Positive Topline Results from its Phase 2b SOOTHE Trial of BLU-5937 for the Treatment of Refractory Chronic Cough
7:00am
6-K
EX-99.2
y2mbu2w 8e
10 Nov 21
Condensed Consolidated Interim Financial Statements of
4:42pm
6-K
EX-99.1
2ved3k
10 Nov 21
BELLUS Health Reports Third Quarter 2021 Financial Results and Business Highlights
4:30pm
6-K
EX-99.1
i2wlqf8xxgtimy
1 Nov 21
Bellus Health Inc. 6-K
7:00am